CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN EQUITY - UNAUDITED - USD ($) shares in Millions, $ in Millions	Total	Total Shareholders' Equity	Preferred Stock	Common Stock	APIC	AOCI	Retained Earnings	NCI
Balance, beginning of year (in shares) at Dec. 31, 2020			0	141
Balance, beginning of year at Dec. 31, 2020	$ 1,263	$ 1,030	$ 0	$ 1	$ 196	$ (417)	$ 1,250	$ 233
Increase (Decrease) in Shareholders' Equity
Net earnings (loss)	(139)	(161)					(161)	22
OCI	(23)	(25)				(25)		2
Issuance of CPS (in shares)			1
Issuance of CPS	582	582			582
Dividends on CPS ($48.75 per share)	(9)	(9)					(9)
Distributions to NCI, net of capital contributions	181							181
NuScale reverse recapitalization		147			147		0	145
Other NCI transactions	(32)	160			160			(192)
Stock-based plan activity	21	21			21
Balance, end of year (in shares) at Sep. 30, 2021			1	141
Balance, end of year at Sep. 30, 2021	1,844	1,598	$ 0	$ 1	959	(442)	1,080	246
Balance, beginning of year (in shares) at Jun. 30, 2021			1	141
Balance, beginning of year at Jun. 30, 2021	1,771	1,516	$ 0	$ 1	883	(417)	1,049	255
Increase (Decrease) in Shareholders' Equity
Net earnings (loss)	38	41					41	(3)
OCI	(23)	(25)				(25)		2
Dividends on CPS ($48.75 per share)	(10)	(10)					(10)
Distributions to NCI, net of capital contributions	94							94
Other NCI transactions	(30)	72			72			(102)
Stock-based plan activity	4	4			4
Balance, end of year (in shares) at Sep. 30, 2021			1	141
Balance, end of year at Sep. 30, 2021	1,844	1,598	$ 0	$ 1	959	(442)	1,080	246
Balance, beginning of year (in shares) at Dec. 31, 2021			1	141
Balance, beginning of year at Dec. 31, 2021	1,567	1,393	$ 0	$ 1	967	(366)	791	174
Increase (Decrease) in Shareholders' Equity
Net earnings (loss)	105	136					136	(31)
OCI	(12)	(12)				(12)		0
Dividends on CPS ($48.75 per share)	(29)	(29)					(29)
Distributions to NCI, net of capital contributions	15							15
NuScale reverse recapitalization	292
Other NCI transactions	1	1			1
Stock-based plan activity (in shares)				1
Stock-based plan activity	14	14			14
Balance, end of year (in shares) at Sep. 30, 2022			1	142
Balance, end of year at Sep. 30, 2022	1,923	1,650	$ 0	$ 1	1,129	(378)	898	273
Balance, beginning of year (in shares) at Jun. 30, 2022			1	142
Balance, beginning of year at Jun. 30, 2022	1,694	1,514	$ 0	$ 1	983	(355)	885	180
Increase (Decrease) in Shareholders' Equity
Net earnings (loss)	(24)	22					22	(46)
OCI	(23)	(23)				(23)		0
Dividends on CPS ($48.75 per share)	(9)	(9)					(9)
Distributions to NCI, net of capital contributions	3							3
NuScale reverse recapitalization	292	147			147		0	145
Other NCI transactions	(3)							(3)
Stock-based plan activity	(1)	(1)			(1)
Balance, end of year (in shares) at Sep. 30, 2022			1	142
Balance, end of year at Sep. 30, 2022	$ 1,923	$ 1,650	$ 0	$ 1	$ 1,129	$ (378)	$ 898	$ 273